Varicose veins treatment Comprehensive Study by Treatment (Surgery, Ligation and Stripping, Sclerotherapy, Radiofrequency Ablation, Endovenous Laser Treatment, Transilluminated Powered Phlebectomy), Disease (Greater Saphenous Varicose Vein, Small Saphenous Varicose Vein, Others), Product (Laser & RF Ablation, Venous Closure, Surgical), Diagnosis (Doppler Test, Color Duplex Ultrasound Scan), End User (Hospitals, Clinics, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2032

Report Objectives / Segmentation Covered

• Surgery
• Ligation and Stripping
• Sclerotherapy
• Radiofrequency Ablation
• Endovenous Laser Treatment
• Transilluminated Powered Phlebectomy

• Greater Saphenous Varicose Vein
• Small Saphenous Varicose Vein
• Others

• Laser & RF Ablation
• Venous Closure
• Surgical

• Doppler Test
• Color Duplex Ultrasound Scan

• Hospitals
• Clinics
• Ambulatory Surgical Centers

• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • Italy
  • United Kingdom
  • Netherlands
  • Rest of Europe
• MEA
  • Middle East
  • Africa
• North America
  • United States
  • Canada
  • Mexico

• 1. Market Overview
  • 1.1. Introduction
  • 1.2. Scope/Objective of the Study
    • 1.2.1. Research Objective
• 2. Executive Summary
  • 2.1. Introduction
• 3. Market Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Rising Incidence and Prevalence of Varicose Veins Worldwide
    • 3.2.2. Increasing Geriatric Population
  • 3.3. Market Challenges
    • 3.3.1. Risk Factors associated with the Treatment Devices
  • 3.4. Market Trends
    • 3.4.1. Technological Advancement in the Varicose Veins Treatment Device
• 4. Market Factor Analysis
  • 4.1. Porters Five Forces
  • 4.2. Supply/Value Chain
  • 4.3. PESTEL analysis
• 5. Global Varicose veins treatment, by Treatment, Disease, Product, Diagnosis, End User and Region (value) (2019-2024)
  • 5.1. Introduction
• 6. Varicose veins treatment: Manufacturers/Players Analysis
  • 6.1. Company Profile
    • 6.1.1. Medtronic plc (Ireland)
      • 6.1.1.1. Business Overview
      • 6.1.1.2. Products/Services Offerings
      • 6.1.1.3. Financial Analysis
      • 6.1.1.4. SWOT Analysis
    • 6.1.2. AngioDynamics, Inc. (United States)
      • 6.1.2.1. Business Overview
      • 6.1.2.2. Products/Services Offerings
      • 6.1.2.3. Financial Analysis
      • 6.1.2.4. SWOT Analysis
    • 6.1.3. Biolitec AG (Austria)
      • 6.1.3.1. Business Overview
      • 6.1.3.2. Products/Services Offerings
      • 6.1.3.3. Financial Analysis
      • 6.1.3.4. SWOT Analysis
    • 6.1.4. Syneron Medical Ltd. (Israel)
      • 6.1.4.1. Business Overview
      • 6.1.4.2. Products/Services Offerings
      • 6.1.4.3. Financial Analysis
      • 6.1.4.4. SWOT Analysis
    • 6.1.5. Lumenis Ltd. (Israel)
      • 6.1.5.1. Business Overview
      • 6.1.5.2. Products/Services Offerings
      • 6.1.5.3. Financial Analysis
      • 6.1.5.4. SWOT Analysis
    • 6.1.6. Dornier MedTech GmbH (Germany)
      • 6.1.6.1. Business Overview
      • 6.1.6.2. Products/Services Offerings
      • 6.1.6.3. Financial Analysis
      • 6.1.6.4. SWOT Analysis
    • 6.1.7. Energist Group (United Kingdom)
      • 6.1.7.1. Business Overview
      • 6.1.7.2. Products/Services Offerings
      • 6.1.7.3. Financial Analysis
      • 6.1.7.4. SWOT Analysis
    • 6.1.8. Eufoton s.r.l. (Italy)
      • 6.1.8.1. Business Overview
      • 6.1.8.2. Products/Services Offerings
      • 6.1.8.3. Financial Analysis
      • 6.1.8.4. SWOT Analysis
    • 6.1.9. Vascular Solutions, Inc. (United States)
      • 6.1.9.1. Business Overview
      • 6.1.9.2. Products/Services Offerings
      • 6.1.9.3. Financial Analysis
      • 6.1.9.4. SWOT Analysis
    • 6.1.10. Quanta System S.p.A. (Italy)
      • 6.1.10.1. Business Overview
      • 6.1.10.2. Products/Services Offerings
      • 6.1.10.3. Financial Analysis
      • 6.1.10.4. SWOT Analysis
• 7. Global Varicose veins treatment Sale, by Treatment, Disease, Product, Diagnosis, End User and Region (value) (2027-2032)
  • 7.1. Introduction
• 8. Appendix
  • 8.1. Acronyms
• 9. Methodology and Data Source
  • 9.1. Methodology/Research Approach
    • 9.1.1. Research Programs/Design
    • 9.1.2. Market Size Estimation
    • 9.1.3. Market Breakdown and Data Triangulation
  • 9.2. Data Source
    • 9.2.1. Secondary Sources
    • 9.2.2. Primary Sources
  • 9.3. Disclaimer

• Table 1. Company Basic Information, Sales Area and Its Competitors
• Table 2. Company Basic Information, Sales Area and Its Competitors
• Table 3. Company Basic Information, Sales Area and Its Competitors
• Table 4. Company Basic Information, Sales Area and Its Competitors
• Table 5. Company Basic Information, Sales Area and Its Competitors
• Table 6. Company Basic Information, Sales Area and Its Competitors
• Table 7. Company Basic Information, Sales Area and Its Competitors
• Table 8. Company Basic Information, Sales Area and Its Competitors
• Table 9. Company Basic Information, Sales Area and Its Competitors
• Table 10. Company Basic Information, Sales Area and Its Competitors
• Table 11. Research Programs/Design for This Report
• Table 12. Key Data Information from Secondary Sources
• Table 13. Key Data Information from Primary Sources

• Figure 1. Porters Five Forces
• Figure 2. Supply/Value Chain
• Figure 3. PESTEL analysis
• Figure 4. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
• Figure 5. Medtronic plc (Ireland) Revenue: by Geography 2024
• Figure 6. AngioDynamics, Inc. (United States) Revenue, Net Income and Gross profit
• Figure 7. AngioDynamics, Inc. (United States) Revenue: by Geography 2024
• Figure 8. Biolitec AG (Austria) Revenue, Net Income and Gross profit
• Figure 9. Biolitec AG (Austria) Revenue: by Geography 2024
• Figure 10. Syneron Medical Ltd. (Israel) Revenue, Net Income and Gross profit
• Figure 11. Syneron Medical Ltd. (Israel) Revenue: by Geography 2024
• Figure 12. Lumenis Ltd. (Israel) Revenue, Net Income and Gross profit
• Figure 13. Lumenis Ltd. (Israel) Revenue: by Geography 2024
• Figure 14. Dornier MedTech GmbH (Germany) Revenue, Net Income and Gross profit
• Figure 15. Dornier MedTech GmbH (Germany) Revenue: by Geography 2024
• Figure 16. Energist Group (United Kingdom) Revenue, Net Income and Gross profit
• Figure 17. Energist Group (United Kingdom) Revenue: by Geography 2024
• Figure 18. Eufoton s.r.l. (Italy) Revenue, Net Income and Gross profit
• Figure 19. Eufoton s.r.l. (Italy) Revenue: by Geography 2024
• Figure 20. Vascular Solutions, Inc. (United States) Revenue, Net Income and Gross profit
• Figure 21. Vascular Solutions, Inc. (United States) Revenue: by Geography 2024
• Figure 22. Quanta System S.p.A. (Italy) Revenue, Net Income and Gross profit
• Figure 23. Quanta System S.p.A. (Italy) Revenue: by Geography 2024

• Medtronic plc (Ireland)
• AngioDynamics, Inc. (United States)
• biolitec AG (Austria)
• Syneron Medical Ltd. (Israel)
• Lumenis Ltd. (Israel)
• Dornier MedTech GmbH (Germany)
• Energist Group (United Kingdom)
• Eufoton s.r.l. (Italy)
• Vascular Solutions, Inc. (United States)
• Quanta System S.p.A. (Italy)

Sciton, Inc. (United States) , Fotona d.o.o. (Slovenia) , BTG plc (United Kingdom) , Merz Aesthetics (United States)